We have recently described an assay in which a temperature-sensitive mutant of vesicular stomatitis virus (VSV; mutant ts045), encoding a glycoprotein that is not transported to the cell surface, can be rescued by expression of wild-type VSV glycoproteins from cDNA (M. Whitt, L. Chong, and J. Rose, J. Virol. 63:3569-3578, 1989). Here we examined the ability of mutant G proteins to rescue ts045. We found that one mutant protein (QN-1) having an additional N-linked oligosaccharide at amino acid 117 in the extracellular domain was incorporated into VSV virions but that the virions containing this glycoprotein were not infectious. Further analysis showed that virus particles containing the mutant protein would bind to cells and were endocytosed with kinetics identical to those of virions rescued with wild-type G protein. We also found that QN-1 lacked the normal membrane fusion activity characteristic of wild-type G protein. The absence of fusion activity appears to explain lack of particle infectivity. The proximity of the new glycosylation site to a sequence of 19 uncharged amino acids (residues 118 to 136) that is conserved in the glycoproteins of the two VSV serotypes suggests that this region may be involved in membrane fusion. The mutant glycoprotein also interferes strongly with rescue of virus by wild-type G protein. The strong interference may result from formation of heterotrimers that lack fusion activity. Vesicular stomatitis virus (VSV) is the prototype rhabdovirus and, like other members of this group, contains a single membrane-spanning spike glycoprotein (G) in its membrane envelope. Infection by many enveloped viruses such as VSV involves binding of the virus to a receptor on the cell surface, internalization by endocytosis, and fusion of the viral envelope with the endosomal membrane (13, 18). For VSV, the membrane fusion event is catalyzed by G protein (7, 22) and occurs in the endosome, where G protein undergoes a conformational change induced by low pH. Viral and endosomal membrane fusion releases the viral nucleocapsid into the cytoplasm and is thus required for infection. Although the amino acid sequences involved in receptor binding and membrane fusion have been determined for several enveloped viruses (see reference 28 for a review), these sequences have not been identified for VSV or other rhabdoviruses. Analysis of mutations in G protein affecting binding, fusion, or release of nucleocapsids should be useful in understanding the early events of infection.
We have recently described an assay in which a temperature-sensitive mutant of vesicular stomatitis virus (VSV; mutant ts045), encoding a glycoprotein that is not transported to the cell surface, can be rescued by expression of wild-type VSV glycoproteins from cDNA (M. Whitt, L. Chong, and J. Rose, J. Virol. 63: [3569] [3570] [3571] [3572] [3573] [3574] [3575] [3576] [3577] [3578] 1989 ). Here we examined the ability of mutant G proteins to rescue ts045. We found that one mutant protein (QN-1) having an additional N-linked oligosaccharide at amino acid 117 in the extracellular domain was incorporated into VSV virions but that the virions containing this glycoprotein were not infectious. Further analysis showed that virus particles containing the mutant protein would bind to cells and were endocytosed with kinetics identical to those of virions rescued with wild-type G protein. We also found that QN-1 lacked the normal membrane fusion activity characteristic of wild-type G protein. The absence of fusion activity appears to explain lack of particle infectivity. The proximity of the new glycosylation site to a sequence of 19 uncharged amino acids (residues 118 to 136) that is conserved in the glycoproteins of the two VSV serotypes suggests that this region may be involved in membrane fusion. The mutant glycoprotein also interferes strongly with rescue of virus by wild-type G protein. The strong interference may result from formation of heterotrimers that lack fusion activity. Vesicular stomatitis virus (VSV) is the prototype rhabdovirus and, like other members of this group, contains a single membrane-spanning spike glycoprotein (G) in its membrane envelope. Infection by many enveloped viruses such as VSV involves binding of the virus to a receptor on the cell surface, internalization by endocytosis, and fusion of the viral envelope with the endosomal membrane (13, 18) . For VSV, the membrane fusion event is catalyzed by G protein (7, 22) and occurs in the endosome, where G protein undergoes a conformational change induced by low pH. Viral and endosomal membrane fusion releases the viral nucleocapsid into the cytoplasm and is thus required for infection. Although the amino acid sequences involved in receptor binding and membrane fusion have been determined for several enveloped viruses (see reference 28 for a review), these sequences have not been identified for VSV or other rhabdoviruses. Analysis of mutations in G protein affecting binding, fusion, or release of nucleocapsids should be useful in understanding the early events of infection.
We have recently described a system for identifying mutations affecting VSV G protein function. G protein expressed from cloned DNA is used to rescue a temperaturesensitive mutant of VSV (tsO45) which makes a defective G protein that is not transported to the plasma membrane at the nonpermissive temperature (31) . This system provides a sensitive assay for examining the ability of mutant glycoproteins to be incorporated into particles or to function in the subsequent steps of virus binding and entry. Using this rescue assay, we were able to demonstrate a requirement for at least part of the normal cytoplasmic tail of VSV G protein in its assembly into virus particles (31) . By using this system to analyze a variety of VSV G proteins carrying mutations in the extracellular domain, it should be possible to localize domains of the glycoprotein involved in later steps of virus infectivity.
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We previously described the generation of point mutations that introduced new sites for asparagine-linked (N-linked) glycosylation in the VSV G protein. Although one of these proteins was misfolded and retained in the endoplasmic reticulum, two others appeared to fold correctly and were transported to the plasma membrane (16, 17) . Here we show that one of the mutants (QN-1) that is transported normally was incorporated into virus particles but that it did not rescue infectivity, apparently because it lacked fusion activity. This mutant also formed heterotrimers with a hybrid G protein that has the wild-type G protein ectodomain and interfered with rescue by wild-type VSV G protein.
Although hydrophobic domains involved in membrane fusion have been identified in several viral fusion proteins (11, 28, 32) , such a domain has not been identified in any rhabdovirus glycoprotein. Because the extra oligosaccharide at amino acid 117 in QN-1 immediately precedes a region consisting largely of uncharged amino acids (residues 118 to 136), we suggest that this domain may be directly involved in the membrane fusion activity of VSV G protein.
MATERIALS AND METHODS
Viruses, cell culture, plasmids, and rescue assay. Stocks of tsO45 and the recombinant vaccinia virus vTF7-3 were prepared as described previously (31) . All cDNAs encoding G protein glycosylation mutants (see Fig. 1 ) were excised with BamHI from pJC119-based plasmids (16) and inserted into the unique BamHI site of pET-3 (25) . Rescue of tsO45 was performed as described previously (31) except that all plasmid transfections were mediated by a modification of the lipofection procedure (6), using dimethyldioctadecyl ammonium bromide (Sigma Chemical Co.) as the cationic lipid (J. Rose, L. Buonocore, and M. Whitt, submitted for publication).
Virus binding assays. The procedure used to determine the amount of virus binding was a modification of that used by Matlin et al. (19) . Virus were performed in duplicate. After binding, the inoculum was removed and the monolayers were washed four times with ice-cold binding medium. The cells were then solibilized in phosphate-buffer saline (PBS) containing 1% Nonidet P-40 (Sigma) and scraped from the dish with a rubber policeman. Duplicate samples were suspended in Ecoscint scintillation fluid (National Diagnostics), and the amount of labeled virus bound was determined. To determine the amount of virus internalized, cells were removed from the plate with PBS containing 50 mM EDTA and then pelleted at 4,000 rpm for 1 min in a microcentrifuge. The cell pellet was resuspended in ice-cold binding medium (pH 7.4) without BSA but containing proteinase K (0.5 mg/ml; Sigma) and incubated on ice for 45 min to remove bound virus remaining on the cell surface. The protease-treated cells were then washed three times with ice-cold binding medium (pH 7.4) containing 0.1% BSA. Cell-associated radioactivity was determined after solubilizing as described above.
Metabolic labeling, immunoprecipitation, and flow cytometry. Baby hamster kidney (BHK-21) cells were infected with vTF7-3 and transfected with the appropriate plasmid(s). Inc.) . Immunoprecipitation of single G proteins was performed as described previously (23) . For coimmunoprecipitation of G protein heterotrimers, cells were solubilized in MNT buffer (pH 5.8) containing 1% Triton X-100 (4), nuclei and cytoskeleton were removed by centrifugation at 14,000 rpm for 2 min in a microcentifuge (Eppendorf), and the cell extracts were precleared by incubation with an irrelevant antiserum for 6 h on ice, followed by incubation with Pansorbin (Calbiochem, Inc.) for an additional 6 h on ice. The supernatants were then divided into three portions and incubated with the appropriate antisera for 6 h on ice. Immune complexes were recovered with Pansorbin and then washed with MNT buffer (pH 5.8) containing 1% Triton X-100. Labeled proteins were resolved on 10% polyacrylamide gels containing sodium dodecyl sulfate (SDS) (14) and visualized by fluorography (1). Quantitation of immunoprecipitated proteins was determined by scanning densitometry as described previously (15) . Flow cytometry was performed as described previously (31) 
RESULTS
The wild-type VSV G protein contains two N-linked oligosaccharides at amino acids 179 and 336. Three mutant VSV G proteins were made in our laboratory previously with single amino acid changes introduced to generate additional sites for oligosaccharide attachment at amino acids 25, 49, and 117 (KT, HS, and QN-1, respectively) (16) . The positions of the mutations are shown in Fig. 1 . Two of the additional sites were glycosylated (KT and QN-1); however, the site designated HS was not glycosylated although a consensus site for glycosylation was introduced (16) .
To examine the effects of these mutations on the abilities of the altered G proteins to assemble into and function in virus particles, we used a system in which transient expression of wild-type G protein from cloned cDNA results in the rescue of the temperature-sensitive mutant of VSV (tsO45) at the nonpermissive temperature (31) . Cells were infected with tsO45, and the indicated G protein was expressed by using the transient system of Fuerst et al. (8) (31) , indicating that QN-1 was incorporated into VSV particles (Fig. 2) . Quantitation of QN-1 present in fractions 6 and 7, relative to the amount of N or M in the same fractions, showed that the amount of QN-1 incorporated was similar to that found for particles rescued with wild-type G protein (31) , indicating that the lack of infectivity observed after rescue of tsO45 with QN-1 was not due to the inability of QN-1 to assemble into virus particles.
Virus (19) .
At least 40% of the binding observed with particles containing QN-1 appeared to be specific because this fraction could be competed with increasing concentrations of wildtype VSV virions (Fig. 3A) . Furthermore, particles containing QN-1 were internalized with kinetics similar to those of rescued virions containing wild-type G protein (Fig. 3B) resulting from the coexpression of two proteins in the rescue assay, we also examined the titers obtained after coexpressing G and an unrelated protein, the alpha subunit of human chorionic gonadotropin (hCG-ot) (12) . Coexpression of QN-1 and wild-type G protein, at a ratio of 1:1.5, respectively, resulted in a 32-fold reduction in the titer of rescued virus compared with the titers found after rescue by coexpression of wild-type G and hCG-ot ( could form heterotrimers with other G proteins, we used a y labeled particles containing either wild-type G protein coimmunoprecipitation assay. This assay relies on the use of -1 (El) were bound to cells as described above. After Lion (Fig. 4) . The lack of fusion by QN-1 was not cytoplasmic domain precipitated both proteins (Fig. 5A ). y reduced surface expression because the level of Sucrose gradient analysis of lysates from cells coexpressing observed by flow cytometry was slightly higher QN-1 and G23 followed by coimmunoprecipitation of the wild-type G control. To determine whether QN-1 trimer peak with the cytoplasmic tail antibodies confirmed ent pH requirement for fusion than wild-type G that QN-1 and G23 were in heterotrimers (data not shown).
examined the fusion activity of either QN-1 or Because the determinants for trimer formation are in the (Fig. SB) . The effect of QN-1 on rescue by GNJ was, in fact, much smaller than that seen for the homologous GI protein (Table 2) ; however, there was still significant interference by QN-1.
DISCUSSION
In this report, we have described the incorporation into virions of a mutated VSV G protein (QN-1) that has an extra The events that bring about fusion of the viral envelope with the endosomal membrane are not understood in precise molecular detail for any virus fusogen. In the case of influenza virus hemagglutinin and several other viral glycoproteins, proteolytic cleavage is required before acid activation in order to expose a critical hydrophobic domain which is thought to insert into the opposing membrane and facilitate redistribution of the two bilayers (28) . For VSV G protein, no posttranslational cleavage occurs and there are no obvious hydrophobic regions that could participate in the fusion reaction. It has been suggested that a domain at the N terminus of G protein may serve as the fusion peptide (26); however, a G protein having a mutation in the critical region retained fusogenic activity equivalent to that of wild-type G protein (33) .
How does the QN-1 mutation interfere with the fusion activity? The VSV G protein, like other fusogenic proteins that act at low pH (10, 13, 18, 27) , is though to undergo a conformational change induced by low pH (2, 4) . This change may expose a hydrophobic domain that inserts into a target membrane (11, 30) . It is conceivable that the extra glycan or the mutation itself might prevent such a conformational change. The only assay available for this conformational change is the stabilization of the G protein trimer at pHs below 6.0 (4). Because trimers formed by the QN-1 mutant are stable at low pH (5), the mutant is probably undergoing a conformational change, although there might well be differences in the conformation from wild-type G protein that prevent fusogenic activity.
An alternative explanation is that the mutation has a more direct effect and falls in or near the fusion domain itself. The hydrophilic glycan would presumably be a strong inhibitor of any membrane binding or insertion. Inspection of the G protein amino acid sequence reveals that the mutation immediately precedes a sequence of 19 uncharged amino acids (residues 118 to 136). Previously, Ohnishi suggested that residues 116 to 148 (residue numbering was changed to correspond to VSV G protein containing the signal sequence) may be involved in the fusion activity of VSV G protein because this sequence is highly conserved between the two VSV serotypes, although it contains several polar residues and is not strongly hydrophobic (20) . Similarly, it has been proposed that a sequence of uncharged amino acids in the ectodomain of Semliki Forest virus El glycoprotein may be involved in membrane fusion (9) . The sequence around the QN-1 mutation clearly deserves further investigation, since a fusion domain has not yet been identified in any rhabdovirus glycoprotein.
The other interesting aspect of the fusion-defective mutant was that it interfered with infection when it was incorporated into VSV particles with the wild-type glycoprotein. When the mutant protein was expressed at levels only 2-fold greater than those of wild-type G protein, the virus titers were reduced 180-fold. Such strong interference might occur through the formation of fusion-inactive heterotrimers of QN-1 and wild-type G protein. (29) . A dominant negative mutation that allowed assembly of the etiological agent and rendered it noninfectious could be more effective than a mutation blocking virus replication, since the host immune system might then respond more effectively to the particles produced. The results presented here suggest that a fusion-defective viral glycoprotein subunit might be very useful in preventing production of infectious virus.
